FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Pixee Medical 510(k) for Knee Procedures

[ Price : $8.95]

FDA clears a Pixee Medical 510(k) for its Knee +, a surgical platform designed to assist orthopedic surgeons by providing real-tim...

BsUFA Reauthorization Steering Committee Ground Rules Set

[ Price : $8.95]

FDA releases summaries from three Biosimilar User Fee reauthorization negotiating sessions.

Panel Backs Keytruda and Tecentriq in Bladder Cancer

[ Price : $8.95]

An FDA advisory committee votes to recommend continued accelerated approvals separately for Mercks Keytruda and Genentechs Tecentr...

Enzyvant Resubmits BLA for Pediatric Congenital Athymia

[ Price : $8.95]

Enzyvant resubmits a BLA for RVT-802, a tissue-based regenerative therapy designed to treat pediatric congenital athymia.

Inspection Delay Impacts Sol-Gel NDA Review

[ Price : $8.95]

A required preapproval inspection delays Sol-Gel Technologies NDA review for Epsolay (benzoyl peroxide) 5% topical cream for treat...

Antisense Oligonucleotide Nonclinical Testing Guidance

[ Price : $8.95]

FDA publishes a draft guidance on nonclinical information supporting an IND for some antisense oligonucleotides.

Court Applies Rule of Reason in Pay-for-Delay Opana Case

[ Price : $8.95]

Attorney Sara Koblitz explains the importance of a recent 5th Circuit Court of Appeals decision in an FTC pay-for-delay case.

Medtronic Breakthrough for Lung Lesion Ablator

[ Price : $8.95]

FDA grants Medtronic a breakthrough device designation for the Emprint ablation catheter kit, which is intended to be used in conj...

Quality in 510(k) Review Pilot Ending

[ Price : $8.95]

FDA says it is concluding the Quality in 510(k) Review pilot program as of 5/30 and recommending that submitters make use of eSTAR...

Saniona Delaying Tesomet Phase 2b Trial to Answer FDA

[ Price : $8.95]

Saniona says responding to an FDA request for Tesomet manufacturing information will delay the start of a Phase 2b trial.